LYKA LABS
Back to All Ratios
|
LYKA LABS Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 3.21 | 3.25 | 2.71 | 1.32 | 0.89 |
What is the latest EV/CE ratio of LYKA LABS ?
Year | EV/CE |
---|---|
Mar2024 | 3.21 |
Mar2023 | 3.25 |
Mar2022 | 2.71 |
Mar2021 | 1.32 |
Mar2020 | 0.89 |
How is EV/CE of LYKA LABS Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 3.21 | -1.23 | |
Mar2023 | 3.25 | 19.93 | |
Mar2022 | 2.71 | 105.30 | |
Mar2021 | 1.32 | 48.31 | |
Mar2020 | 0.89 | - |
Other Financial Ratios of LYKA LABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹556.0 Cr | -1.3% | -3.7% | 22.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -1.3% |
-3.7% |
22.8% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses